Post-partum (PP) in dairy cows is the period that most influences the productive and reproductive efficiency of the animal (1). To allow a new pregnancy occurs the female genital apparatus undergoes physiological changes, such as uterine involution, epithelial regeneration, elimination of bacteria and resumption of ovarian cyclicity (2). Uterine involution is characterized by a series of macroscopic, microscopic and molecular events. The macroscopic ones affect the volume and weight of the uterus, while the microscopic ones concern regeneration. These changes are characterized by the phenomena of necrosis and desquamation of the caruncles and regeneration of the endometrium, which lead to a decrease in the weight of the organ, from an average weight of 13 kg before delivery to 1 kg 30 days later (3). These events are intended to ensure that the uterus regains suitable conditions for a new gestation (2). Furthermore, the molecular changes characterized by the reconstitution of Ca²⁺ and glucose reserves are crucial for the proper resumption of uterine contractility. The latter, after an initial increase, undergoes a reduction in the frequency and number of contractions to about 14 per hour in the next few hours after delivery; in the next 42 h, contractile events must further reduce to 1 per hour to ensure that placental retention does not occur (4). Complete uterine involution is reached around 40–50 days PP (2). The number of days required for proper involution increases in cows that have experienced complications during parturition (e.g., dystocias) or retention of fetal membranes; in these cows the risk of developing a uterine infection increases, as the possibility of bacterial colonization is greater (5). Failure of the uterus and cervix to return to normal size, in particular a cervical diameter of 7.5 cm, between 20 and 33 days PP, is associated with a reduced rate of conception as reported by LeBlanc et al. (6). Several pharmacological approaches are used to condition PP, all of which focus on modulating the contractile activity of the uterus. Currently, ecbolic drugs such as oxytocin (OX) and natural or synthetic Prostaglandin F2α (PGF2α) analogs are widely used in cattle breeding (7–9). There are conflicting opinions on the use of such ecbolics. Treatment with OX has a positive effect on uterine contractility up to day 2 PP, given its low half-life (7). The administration of PGF2α has a positive effect on uterine involution (8, 9), promoting a rapid completion of the process and a rapid recovery of ovarian activity (10). Stephen et al. (11), on the other hand, compared the two ecbolics administered for 1 week postpartum and found no positive effects on uterine involution, incidence of endometritis and reproductive performance. The parasympathetic nervous system also regulates the contractile activity of the uterus, promotes its vascularization and stimulates secretion from the cervical glands (12, 13). These activities are mediated by acetylcholine, which binds to muscarinic receptors, M2 and M3. Binding to the M2 receptor prevents relaxation of the uterus, while binding to the M3 receptor promotes its contraction (14). The distribution of the receptors is regulated by the hormone most present: estrogens stimulate the synthesis of the M2 receptor, while reducing that of the M3 receptor. In the 24 h after delivery, estrogens are still present in high concentrations and, therefore, M2 receptors are the most prevalent muscarinic receptor subtypes (15). Rizzo et al. (16) evaluated the effect of an antimuscarinic (parasympatholytic) drug, scopolamine, administered within 24 h after calving, to regularize uterine contractions and, thus, improve uterine involution in dairy cows. Scopolamine has proved to be a valid alternative to traditional ecbolic substances in the management of PP in dairy cows, regularizing uterine contractility by blocking, for the duration of its half-life (2–3 h), uterine contractions in PP, which are then more efficient and regular when they resume (16). The aim of the present study was to compare the effect of three substances with ecbolic activity, Oxytocin, PGF2α and Scopolamine, administered within 24 h of calving, on the uterine involution process in dairy cows and on the resumption of ovarian activity. To compare the efficacy of these drugs, hydroxyproline (HYP) levels, an important marker of uterine involution (16), ultrasound examination, for the measurement of the diameter of the uterine horns and reproductive indices (days to first service and number of artificial insemination for conception) were evaluated.

All procedures were conducted in accordance with animal welfare and use guidelines, with the informed consent of the owner and approval of the ethics committee (protocol no. 10/2023).

The administration of all drugs did not produce any side effects. In the group C, two cows reported an acute metritis; in the group PG one cow showed subacute metritis; in the group OX one cow reported the left abomasal displacement and two cows follicular cyst; in the group S, one cow showed follicular cysts. These cows were not included in the experimental study.

The aim of the present study was to compare the effect of three substances with ecbolic activity, Oxytocin, PGF2α and Scopolamine, administered within 24 h of calving, on the uterine involution process in dairy cows and on the resumption of ovarian activity. The first two are conventional ecbolic drugs, commonly used, while scopolamine is an parasympatholytic drug that it was demonstrated to have ecbolic activity, regularizing uterine contractility (16). In present study, the efficacy of these drugs has been demonstrated by assaying HYP concentration, marker of uterine involution (16, 19). It increased from T0 to T28 in all groups, with concentrations lower in control group than the other groups. This confirm that the treatments with PGF2α, oxytocin and scopolamine, administrated within 24 h after calving, induced an improvement of uterine involution. They may have acted through their tonic effect on uterus, increasing the myometrial contractions and, consequently, improving the reduction of the organ and the clearance of intrauterine fluid (20, 21). HYP, in fact, is produced following to the uterine collagen fiber degradation, during the involution process (19). Among experimental groups, the higher HYP concentrations, at T28, are shown in groups PG and S. These results are also confirmed by those obtained with ultrasonography: in fact, the diameters of ex-pregnant uterine horn were reduced from T14 to T28, with values lower in groups PG and S than C and OX groups. It was hypothesizable that uterine involution was improved with PGF2α administration, as prostaglandins act not only on contractile activity but also on activation of the immune response and triggering of phagocytosis (9, 17). Moreover, prostaglandins act on contraction of cervical smooth muscle, promoting remodeling of the structure (22). Then, these activities can explain the higher HYP levels showed in group PG. In the S group, also, higher HYP concentrations were obtained. It is hypothesizable that, in this group, rebound effect was exploited, with positive influences on the involution of the organ, in agreement with Rizzo et al. (16). In other word, scopolamine temporarily has blocked the uterus contractions, for a period of time corresponding to its half-life (2–3 h). Following the disappearance of its pharmacological effect, the uterus has resumed contracting more effectively and increased glandular secretions, useful for self-cleansing activity. Moreover, it was demonstrated that the activation of muscarinic receptors M3 in muscle cells stimulates glucose uptake, essential element for the contractility (23). The activity on uterine involution by scopolamine could thus be attributed to both a regularization of contractility and an increase in contractile force due to increased glucose up-take. The efficacy of scopolamine on uterine involution was then demonstrated by both the high HYP levels and the reduction of the uterine horn diameters. In OX-treated subjects, on the other hand, there is an increase in the frequency of uterine contractions that promote the reduction of uterine volume, but immune stimulation is lacking. This would explain the lower HYP concentrations recorded in the OX group cows compared with the groups. Oxytocin, therefore, acting only on uterine contractility, was not as effective, in reducing diameters, as the other two drugs tested. In literature, Oxytocin and prostaglandin were used to influence the evolution of postpartum. However, there are conflicting opinions. Stephen et al. (11) compared the effect of oxytocin and dinoprost, administered for the first 7 days postpartum, on uterine involution, postpartum endometritis, and reproductive performance. The Authors concluded that these ecbolic drugs, as used in this study, were not recommended for use in clinical practice to improve involution or reproductive tract health in normal cows (11). On the other hand, Abdel-Khalek et al. (21) demonstrated that cows, treated with oxytocin or PGF2α within 6–12 h postpartum, showed similar results in terms of diameters of uterine horns (gravid and non-gravid), cervical and vaginal length than that occurred in the control cows. Moreover, the authors concluded that PGF2α and oxytocin treatment showed similar beneficial effects on uterine involution, meanwhile prostaglandin treatment obtained the best results on conception rate and number of services per conception within 90 days-post-partum (21).

As reproductive indices in present study, group S achieved the best results, in terms of days to first service that were less than other groups. It is known that the ovarian recovery is closely correlated with good uterine involution. Therefore, in this group, the improvement of the reproductive efficacy may be due to the scopolamine activity that regularize the uterine contractility but it also acts on vascularization (13) and on cervical glandular secretion (12). These activities are important for improving uterine clearance and, thus, allowing earlier resumption of reproductive function.

The results of this study support the use of ecbolics in the immediate postpartum period to accelerate uterine involution and improve the reproductive efficiency of the dairy cow. Treatment with Scopolamine and PGF2α resulted in better outcomes, evidenced clinically by more efficient uterine involution and faster ovarian recovery.

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

All procedures were conducted in accordance with animal welfare and use guidelines, with the informed consent of the owner and approval of the ethics committee (protocol no. 10/2023). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the owners for the participation of their animals in this study.

AC: Conceptualization, Investigation, Methodology, Writing – original draft. MB: Data curation, Methodology, Writing – original draft. LF: Investigation, Methodology, Writing – original draft. EC: Investigation, Methodology, Writing – original draft. MS: Data curation, Writing – original draft. PR: Investigation, Writing – original draft. VC: Data curation, Methodology, Writing – original draft. AR: Conceptualization, Data curation, Methodology, Project administration, Supervision, Writing – original draft.